MADE EASY
COMPLEX SCREENING MADE EASY
technology accelerates screening of predictive disease models earlier in drug discovery
Our approach to drug screening is simple: we create physiologically relevant disease models to test drug efficacy using the a variety of cell and tissue sources. This disease complexity is miniaturized and scaled up to meet the expectations of data throughput in mid- to late-drug discovery processes. We develop our technology in microplate format to integrate our technology with established automated workflows. This ensures scalability, as well as time- and resource-efficient assays, while reproducing in vivo like conditions during drug tests.
EXPLORE
BENEFITS
Long-term culture
of 3D models
No tubing and
no rocking plates
Controlled
shear stress free
perfusion
Unique
miniaturization for
combination studies
20X more data for
the same starting
material
Get results
twice as fast
Compatible
with imaging and
robotic dispenser
EXPLORE
BENEFITS
Long-term culture of biopsy-derived and in vitro complex models
No tubing and no rocking plates
Shear stress free perfusion controls dynamic on-chip environments
Unique miniaturization for combination studies
20X more data throughput for the same amount of starting material
Get results twice as fast
Straight forward integration with imaging equipment and robotic dispensers
EXPLORE
BENEFITS
Long-term culture
of 3D models
No tubing and
no rocking plates
Controlled
shear stress free
perfusion
Unique
miniaturization for
combination studies
20X more data for
the same starting
material
Get results
twice as fast
Compatible
with imaging and
robotic dispenser
OUR SOLUTIONS FOR DRUG DISCOVERY
